CAR Surges 61% as EPS Revisions Spark Industrials Rally — 6 Stocks Jump
CAR led gains with a 61.3% surge from $255.15 to $411.56 after analysts raised next-year EPS growth from 100.6% to 104.7% on April 6. The EPS revision screener detected the move early, with BE benefiting from AI infrastructure tailwinds tied to Microsoft's 3,200-acre data center purchase. TVTX posted the largest EPS revision at +29.1pp, driving its 33.0% rally, suggesting strong earnings momentum across Industrials and Healthcare sectors.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| CAR | Industrials | 2026-04-06 | +4.1pp | +61.3% |
| FFAI | Consumer Cyclical | 2026-04-06 | +12.9pp | +40.9% |
| KEEL | Industrials | 2026-04-06 | N/A | +39.2% |
| BE | Industrials | 2026-04-09 | +1.5pp | +36.8% |
| TVTX | Healthcare | 2026-04-08 | +29.1pp | +33.0% |
Why did CAR stock jump in April 2026?
CAR jumped 61.3% from $255.15 to $411.56 after analysts raised its forward EPS growth estimate from 100.6% to 104.7% on April 6.
Avis Budget Group, a vehicle rental and leasing company in the Industrials sector, saw its profit outlook improve as used-car values stabilized and fleet utilization increased. The screener caught the revision before the stock embarked on its sustained rally, with institutional buying accelerating as the earnings trajectory strengthened.
View screener snapshot from 2026-04-06 →
FAQ: CAR
Why did CAR stock jump 61% in April 2026?
CAR surged 61.3% from $255.15 to $411.56 after analysts raised its forward EPS growth estimate from 100.6% to 104.7% on April 6, signaling improved profitability outlook for the vehicle rental company.
Is CAR a buy after its 61% rally?
CAR has delivered 61.3% gains since the April 6 EPS revision, with next-year EPS growth now projected at 104.7%, though the sharp run-up may limit immediate upside for new buyers.
What caused the Avis Budget Group stock surge?
The surge was triggered by a +4.1 percentage point upward revision to forward EPS growth (100.6% to 104.7%) detected by the screener on April 6, driven by stabilizing used-car values and improving fleet demand.
Why did FFAI stock jump in April 2026?
FFAI surged 40.9% from $0.22 to $0.31 after analysts raised its forward EPS growth estimate from 50.3% to 63.2% on April 6.
Faraday Future, an EV manufacturer in the Consumer Cyclical sector, saw its profit outlook brighten as production ramped at its California facility. The screener identified the revision early, with short-covering amplifying gains given the low float and high short interest typical of penny-stock EVs.
View screener snapshot from 2026-04-06 →
FAQ: FFAI
Why did FFAI stock jump 40% in April 2026?
FFAI jumped 40.9% from $0.22 to $0.31 after analysts raised its forward EPS growth estimate from 50.3% to 63.2% on April 6, reflecting improved production and profitability expectations for the EV maker.
Is FFAI a good investment after its 40% rally?
FFAI has surged 40.9% since the revision but remains a speculative penny-stock EV company; the +12.9pp EPS upgrade signals accelerating earnings potential but carries high volatility risk.
What is driving Faraday Future stock higher?
Faraday Future's rally stems from a +12.9 percentage point upward revision to forward EPS growth (50.3% to 63.2%), indicating improved production capacity and demand outlook for its premium electric vehicles.
Why did KEEL stock jump in April 2026?
KEEL climbed 39.2% from $2.04 to $2.84 after the screener detected a 43.7% forward EPS growth projection on April 6.
Keel Infrastructure Corp, an Industrials play on construction and infrastructure development, benefits from anticipated infrastructure spending and contract wins. The screener flagged the earnings potential early, with momentum investors piling in as the stock cleared key technical levels on elevated volume.
View screener snapshot from 2026-04-06 →
FAQ: KEEL
Why did KEEL stock surge 39% in April 2026?
KEEL climbed 39.2% from $2.04 to $2.84 after the screener detected a 43.7% forward EPS growth projection on April 6, driven by infrastructure spending tailwinds and contract momentum.
Is KEEL a buy after its infrastructure-driven rally?
KEEL has gained 39.2% since the April 6 detection with 43.7% projected EPS growth, but investors should assess whether the infrastructure spending catalyst remains intact before entering.
What caused the Keel Infrastructure stock surge?
Keel Infrastructure's rally was powered by a 43.7% forward EPS growth estimate detected by the screener, with infrastructure sector tailwinds and contract announcements fueling the 39.2% price surge.
Why did BE stock jump in April 2026?
BE rallied 36.8% from $160.13 to $219.03 after analysts raised its forward EPS growth estimate from 106.9% to 108.4% on April 9.
Bloom Energy, a clean-energy power generation company, received a boost from Microsoft's 3,200-acre data center land purchase and Oracle's $3 billion Bloom Energy AI deal announcement. The screener caught the EPS revision just before the news catalyzed broader AI-infrastructure buying, driving the stock to fresh highs.
View screener snapshot from 2026-04-09 →
FAQ: BE
Why did BE stock jump 37% in April 2026?
BE surged 36.8% from $160.13 to $219.03 after analysts raised its forward EPS growth from 106.9% to 108.4% on April 9, catalyzed by Oracle's $3 billion AI deal and Microsoft's data center expansion.
Is Bloom Energy a buy after its 37% rally?
BE has gained 36.8% since April 9 with 108.4% projected forward EPS growth, supported by a major Oracle contract and AI infrastructure demand, though valuation has become stretched after the run-up.
What is driving Bloom Energy stock higher?
Bloom Energy's rally stems from a +1.5pp upward revision to forward EPS growth (106.9% to 108.4%) combined with Oracle's $3 billion AI deal and increased demand for power generation in data center builds.
Why did TVTX stock jump in April 2026?
TVTX climbed 33.0% from $31.68 to $42.13 after analysts raised its forward EPS growth estimate from 519.7% to 548.8% on April 8.
Travere Therapeutics, a Healthcare biotech specializing in rare disease treatments, saw its profit forecast surge as pipeline milestones approached and cost controls improved. The screener detected the largest revision at +29.1pp, with clinical trial catalysts and potential FDA decisions fueling optimism for the specialty pharma company.
View screener snapshot from 2026-04-08 →
FAQ: TVTX
Why did TVTX stock jump 33% in April 2026?
TVTX climbed 33.0% from $31.68 to $42.13 after analysts raised its forward EPS growth from 519.7% to 548.8% on April 8, driven by rare disease pipeline momentum and improved cost outlook.
Is TVTX a buy after its biotech rally?
TVTX has gained 33.0% since the +29.1pp EPS revision with 548.8% projected forward growth, but biotech-specific risks including trial outcomes and FDA decisions warrant careful due diligence.
What caused the Travere Therapeutics stock surge?
Travere Therapeutics' rally was triggered by a +29.1 percentage point upward revision to forward EPS growth (519.7% to 548.8%), reflecting pipeline progress and operational improvements at the rare disease drug developer.
Earnings estimate revisions are driving significant alpha with six stocks gaining over 33% since detection, particularly in Industrials where five of six gainers reside. The concentration of strong EPS upgrades—ranging from +1.5pp to +29.1pp—suggests analysts are signaling accelerating profitability expectations, with AI-infrastructure and clean-energy plays like BE capturing sector rotation interest.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →